Study of assessment of susceptibility with focus on respiratory tract infection in age group of 18 years to 40 years.

Assessment of susceptibility with focus on respiratory tract infection in age group of 18 years to 40 years.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/06/034157

Enrollment

Registered

2021-06-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

Intervention1: Homoeopathic similimum: Potentized homoeopathic medicine in the form of pills powder and dilution. Dose: The final selected remedy based on the individual totality will be prescribed in

Eligibility

Inclusion criteria

Inclusion criteria: 1. Various socioeconomic groups will be included. 2. Patients of 18 - 40 years of age groups who fulfilled the standard case definition. 3. Patients of both sexes will be included in the study. 4. Patient without any other systemic diseases. 5. Patient giving written consent form.

Exclusion criteria

Exclusion criteria: 1. That doesnâ??t fulfil the diagnostic criteria. 2. Patients of regular medical care for any other chronic conditions like congenital malformation of respiratory tract, specific lungs disease. 3. Patients undertaking immune suppressive therapy will be excluded. 4. Patients with Psychiatric diagnosis. 5. Recent major surgery. 6. Patients requiring emergency medical care. 7. Patients who have participated in any other Research study in the last 6 months. 8. Those under other medications. Or using any other medicine during the study period. 9. Pregnant and lactating women. 10. Patient who are not written the consent form.

Design outcomes

Primary

Measure	Time frame
1. Improvement in the Wisconsin-Upper-Respiratory-Symptom-Survey-21 before and after the treatment. 2. To investigate the utility and efficacy of homoeopathic medicine for the treatment of acute and recurrent URTIs.Timepoint: 1. Improvement in the Wisconsin-Upper-Respiratory-Symptom-Survey-21 at day 1 and again after every 15 days, for the total of 3 months. 2. Quality of life questionnaire assessment will be done in every follow-up for 3 months.	—

Measure

Time frame

1. Improvement in the Wisconsin-Upper-Respiratory-Symptom-Survey-21 before and after the treatment. 2. To investigate the utility and efficacy of homoeopathic medicine for the treatment of acute and recurrent URTIs.Timepoint: 1. Improvement in the Wisconsin-Upper-Respiratory-Symptom-Survey-21 at day 1 and again after every 15 days, for the total of 3 months. 2. Quality of life questionnaire assessment will be done in every follow-up for 3 months.

—

Secondary

Measure	Time frame
To observe the changes in quality of life of patient with acute and recurrent URTIs after taking treatment.Timepoint: Assessment on day 1 and after 3 months.	—

Countries

India

Contacts

Public ContactDr Moirangthem Krishnakumari Devi

Bharati Vidyapeeth Deemed to be University Homoeopathic Medical College, Pune

dr.vinodinipatil@gmail.com9890127840

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026